Christopher Martell - Director at Candel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
CADL on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Christopher Martell since 08 Feb 2025

Holdings reported by Christopher Martell for Candel Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 283,514 $1,363,702 $4.81 25 Jun 2025 By GTAM1 2012 ADV LLC
Common Stock 152,000 $731,120 $4.81 25 Jun 2025 By GTAM1 2012 LLC
Common Stock 111,349 $519,999 $4.67 25 Jun 2025 By Spouse
Stock Option (Right to Buy) 14,240 17 Jun 2025 Direct Common Stock

Transactions reported by Christopher Martell for Candel Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.